Ambiq Micro, Inc.
NYSE:AMBQSemiconductors
+$5.10 today
- Market cap
- $1.14B
- Beta
- 5.68
- P/E (TTM)
- -44.8
- EPS (TTM)
- -$1.88
Volume 0.30M
Average 0.58M
AMBQ Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Ambiq Micro, Inc.NYSE: AMBQ
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization dips below year-ago levels
Q1 FY2026 depreciation & amortization of $1.74M fell 11.3% year over year, behind the +5.2% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 5.6% from the prior quarter.
Context
- Depreciation & amortization amounted to 9.9% of revenue in FY2025, up 1.7 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -11.3% toward the trailing-twelve-month pace of +5.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 7.22M USD
- Year-over-year change
- +15.5%
- 5-year CAGR
- +30.2%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.22M | +15.5% |
| FY2024 | 2024-12-31 | 6.25M | -19.1% |
| FY2023 | 2023-12-31 | 7.72M | — |
| FY2021 | 2021-12-31 | 2.61M | +35.6% |
| FY2020 | 2020-12-31 | 1.93M | — |
Depreciation & Amortization vs competitors
How AMBQ compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +5.2% is the 6th highest of 10, against a peer median of +5.2%.
- Depreciation & amortization amounts to 8.5% of revenue for AMBQ, versus a peer median of 6.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $198M USD | -17.4% | +31.3% | 27.8% | |
| LTM Mar 2026 | $18.26M USD | -37.4% | +8.3% | 12.2% | |
| LTM Mar 2026 | $16.03M USD | +5.2% | -2.1% | 6.4% | |
| LTM Apr 2026 | $14.81M USD | -33.9% | -0.6% | 4.7% | |
| LTM Mar 2026 | $9.73M USD | -11.8% | -23.9% | 3.2% | |
| LTM Jun 2026 | $9.57M USD | +6.0% | +3.9% | 7.6% | |
AMBQAmbiq Micro, Inc. | LTM Mar 2026 | $6.99M USD | +5.2% | — | 8.5% |
| LTM Mar 2026 | $3.88M USD | +15.0% | +17.2% | 5.0% | |
| LTM Mar 2026 | $3.55M USD | +59.4% | +36.9% | 251.3% | |
NBPNovaBridge Biosciences | LTM Sep 2025 | CN¥1.54M CNY | — | -76.2% | — |
| LTM Mar 2026 | $1.19M USD | +44.4% | -24.3% | 2.9% | |
| Peer median (excluding AMBQ) | — | +5.2% | +1.6% | 6.4% | |
Competitors are the stored peer set for AMBQ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2020 Dec 2020 | FY2021 Dec 2021 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (25.22M) | (25.34M) | (50.33M) | (39.66M) | (36.46M) |
| Depreciation & Amortization | 1.93M | 2.61M | 7.72M | 6.25M | 7.22M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 702K | 1.29M | 2.62M | 5.17M | 6.84M |
| Change in Working Capital | (16.89M) | (36.58M) | 12.91M | 5.11M | 3.47M |
| Accounts Receivables | (136K) | (10.88M) | (2.98M) | 1.75M | 3.23M |
| Inventory | (3.61M) | (26.46M) | 15.16M | 6.04M | (2.13M) |
| Accounts Payables | (1.55M) | 8.23M | (3.94M) | 821K | 4.2M |
| Other Working Capital | (11.59M) | (7.46M) | 4.67M | (3.51M) | (1.82M) |
| Other Non-Cash Items | 4.84M | 5.14M | 125K | 1.7M | (753K) |
| Operating Cash Flow | (34.64M) | (52.88M) | (26.96M) | (21.43M) | (19.69M) |
| Capital Expenditures | (4.59M) | (4.62M) | (3.02M) | (3.73M) | (1.34M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (1.96M) | 0 | (2.56M) | (3.07M) | (6.1M) |
| Investing Cash Flow | (4.59M) | (4.62M) | (3.02M) | (3.73M) | (7.44M) |
| Debt Repayment | 8.77M | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 58.84M | 109.21M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (2.35M) | 354K | 516K | 0 | (2.83M) |
| Financing Cash Flow | 94.07M | 18.2M | 31.77M | 58.84M | 106.38M |
| Effect of Forex Changes | (53K) | 176K | (254K) | (24K) | 43K |
| Net Change in Cash | 54.78M | (39.13M) | 1.54M | 33.66M | 79.29M |
| Free Cash Flow | (39.23M) | (57.5M) | (29.98M) | (25.16M) | (21.03M) |
Ambiq Micro, Inc.
NYSE:AMBQ
Intrinsic Alpha fair value
Locked
Current Price
$45.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.